# US 2022/0008753 A1 · Method and apparatus for pulmonary interventions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0008753 A1
- Document ID: US20220008753A1
- Status: Published application
- Kind: A1
- Application number: 17/391,486
- Filed: 2021-08-02
- Published: 2022-01-13
- Earliest claimed: 2020-03-31
- Assignees: AerWave Medical, Inc.
- Applicants: AerWave Medical, Inc.
- Inventors: Reinhard J. Warnking; Satoshi Nishiaoki
- Web page: https://patentgrep.com/patent/US20220008753A1

## CPC

- A61N 7/00: Ultrasound therapy (lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 {; using ultrasound for introducing media into the body A61M37/0092})
- A61B 8/085: {for locating body or organic structures, e.g. tumours, calculi, blood vessels, nodules}
- A61B 8/12: in body cavities or body tracts, e.g. by using catheters
- A61B 8/429: {characterised by determining or monitoring the contact between the transducer and the tissue}
- A61B 8/445: {Details of catheter construction}
- A61N 7/022: {intracavitary}
- A61B 1/00082: {Balloons}
- A61B 34/73: {Manipulators for magnetic surgery}
- A61B 2018/00541: {Lung or bronchi}
- A61N 2007/0004: {Applications of ultrasound therapy}
- A61N 2007/003: {Destruction of nerve tissue}
- A61N 2007/0043: {intra-cavitary}
- A61N 2007/0052: {using the same transducer for therapy and imaging}
- A61N 2007/0082: {Scanning transducers}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Apparatus and methods for deactivating bronchial nerves extending along the secondary bronchial branches of a mammalian subject to treat asthma and related conditions. An ultrasonic transducer (11) is inserted into the bronchus as, for example, by advancing the distal end of a catheter (10) bearing the transducer into the secondary bronchial section to be treated. The ultrasonic transducer emits circumferential ultrasound so as to heat tissues throughout circular impact volume (13) as, for example, at least about 1 cm3 encompassing the bronchus to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual bronchial nerves. The apparatus and methods utilized for lung tumor ablation.

## Claims

### Claim at position 1

1-18. (canceled)

### Claim 19

Apparatus for inactivating bronchial nerve conduction in a mammalian subject, comprising:
an ultrasound transducer adapted for insertion into secondary bronchial sections of the mammalian subject and for emitting ultrasound energy; and
an actuator or control unit electrically connected to the ultrasound transducer, the actuator or control unit being configured to control the ultrasound transducer to transmit ultrasound energy into an impact volume of at least approximately 1 cm3 at least partially surrounding the bronchial section, the ultrasound energy being in an amount effective to inactivate conduction of bronchial nerves throughout the impact volume.

### Claim 20 (depends on 19)

The apparatus of claim 19, wherein the actuator or control unit is configured to control the ultrasound transducer to transmit ultrasound energy at an acoustic power level of approximately 10 to approximately 20 watts for approximately 10 to approximately 20 seconds to provide a dose of approximately 100 to approximately 400 joules in the impact volume.

### Claim 21 (depends on 19)

The apparatus of claim 19 wherein the actuator or control unit is configured to control the ultrasound transducer to transmit ultrasound energy in a pulsed mode to cause mechanical stress on nerve fibers through cavitational effects.

### Claim 22 (depends on 19)

The apparatus of claim 19, wherein the actuator or control unit is configured to control the transducer and cooling fluid circulation so as to maintain temperature of a section of bronchial wall of the bronchial section below 65° C. while achieving a temperature above 42° C. throughout the impact volume.

### Claim at position 6

23-30. (canceled)
